Literature DB >> 22996396

Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients.

Emi Miki1, Tsuyoshi Kataoka, Hitoshi Okamura.   

Abstract

BACKGROUND: The number of elderly cancer patients has been rising in recent years, and decreases in cognitive function are reportedly seen in 25-50% of these patients. However, no validated and practical tests are available for the assessment of cognitive function in cancer patients. Age and the effects of cancer treatment have been pointed out as possible causes of these decreases in cognitive function; in both instances, a strong possibility of a decrease in frontal lobe function exists.
METHODS: We administered the Frontal Assessment Battery at bedside (FAB), the Mini-Mental State Examination (MMSE), the Barthel Index, and the Instrumental Activities of Daily Living (IADL) to 54 cancer patients who were 65 years of age or older and assessed the clinical usefulness of the FAB.
RESULTS: The results showed that the FAB scores were significantly correlated with the MMSE and IADL scores and were unaffected by the number of years of education. Moreover, when the subjects were divided into two groups according to whether their total FAB score was less than 16 points or 16 points or more, significant differences in the total MMSE scores and the total IADL scores were observed.
CONCLUSIONS: Based on these findings and because the FAB sensitively detected decreases in cognitive function, accurately reflected the status of everyday life, and could be performed conveniently and in a short time, we concluded that the FAB may be very useful clinically as a means of evaluating the cognitive function of elderly cancer patients.

Entities:  

Mesh:

Year:  2012        PMID: 22996396     DOI: 10.1007/s00520-012-1595-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  Future thinking in Parkinson's disease: an executive function?

Authors:  Stefania de Vito; Nadia Gamboz; Maria Antonella Brandimonte; Paolo Barone; Marianna Amboni; Sergio Della Sala
Journal:  Neuropsychologia       Date:  2012-03-08       Impact factor: 3.139

2.  The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.

Authors:  Christina A Meyers; Jeffrey S Wefel
Journal:  J Clin Oncol       Date:  2003-08-11       Impact factor: 44.544

3.  A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.

Authors:  Catherine E Jansen; Christine Miaskowski; Marylin Dodd; Glenna Dowling; Joel Kramer
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

4.  Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia.

Authors:  Eric Guedj; Gilles Allali; Celine Goetz; Isabelle Le Ber; Magali Volteau; Lucette Lacomblez; Pierre Vera; Anne Hitzel; Didier Hannequin; Marielle Decousus; Catherine Thomas-Antérion; Christine Magne; Martine Vercelletto; Anne-Marie Bernard; Mira Didic; Jean-Albert Lotterie; Michèle Puel; Alexis Brice; Marie-Odile Habert; Bruno Dubois
Journal:  J Neurol Sci       Date:  2008-10-15       Impact factor: 3.181

5.  The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.

Authors:  Gordon Winocur; Janette Vardy; Malcolm A Binns; Leslie Kerr; Ian Tannock
Journal:  Pharmacol Biochem Behav       Date:  2006-08-28       Impact factor: 3.533

6.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Reliability and validity of the Japanese version of the Frontal Assessment Battery in patients with the frontal variant of frontotemporal dementia.

Authors:  Shutaro Nakaaki; Yoshie Murata; Junko Sato; Yoshihiro Shinagawa; Teruo Matsui; Hiroshi Tatsumi; Toshi A Furukawa
Journal:  Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.188

Review 8.  Cognitive effects of hormone therapy in men with prostate cancer: a review.

Authors:  Christian J Nelson; Jennifer S Lee; Maria C Gamboa; Andrew J Roth
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

9.  Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

Authors:  J Vardy; J S Wefel; T Ahles; I F Tannock; S B Schagen
Journal:  Ann Oncol       Date:  2007-10-31       Impact factor: 32.976

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  1 in total

1.  FAB-D: German version of the Frontal Assessment Battery.

Authors:  Thomas Benke; Elfriede Karner; Margarete Delazer
Journal:  J Neurol       Date:  2013-05-07       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.